These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17038479)

  • 1. Use of cell permeable NBD peptides for suppression of inflammation.
    Strickland I; Ghosh S
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii75-82. PubMed ID: 17038479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide.
    Davé SH; Tilstra JS; Matsuoka K; Li F; Karrasch T; Uno JK; Sepulveda AR; Jobin C; Baldwin AS; Robbins PD; Plevy SE
    J Immunol; 2007 Dec; 179(11):7852-9. PubMed ID: 18025231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.
    Baima ET; Guzova JA; Mathialagan S; Nagiec EE; Hardy MM; Song LR; Bonar SL; Weinberg RA; Selness SR; Woodard SS; Chrencik J; Hood WF; Schindler JF; Kishore N; Mbalaviele G
    J Biol Chem; 2010 Apr; 285(18):13498-506. PubMed ID: 20167598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
    De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
    Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
    Dai S; Hirayama T; Abbas S; Abu-Amer Y
    J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.
    Tas SW; Vervoordeldonk MJ; Hajji N; May MJ; Ghosh S; Tak PP
    Arthritis Res Ther; 2006; 8(4):R86. PubMed ID: 16684367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEMO-binding domain peptides alleviate perihematomal inflammation injury after experimental intracerebral hemorrhage.
    Luo Q; Li D; Bao B; Wan X; Pan B; Tu J; Wang H; Ouyang Y; Chen Z; Yin X
    Neuroscience; 2019 Jun; 409():43-57. PubMed ID: 31047976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.
    May MJ; D'Acquisto F; Madge LA; Glöckner J; Pober JS; Ghosh S
    Science; 2000 Sep; 289(5484):1550-4. PubMed ID: 10968790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
    Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
    BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
    Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
    Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation.
    Grassia G; Maddaluno M; Musilli C; De Stefano D; Carnuccio R; Di Lauro MV; Parratt CA; Kennedy S; Di Meglio P; Ianaro A; Maffia P; Parenti A; Ialenti A
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2458-66. PubMed ID: 20930169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation.
    Liu H; Yan Z; Zhao Y; Ma X; Zhang H; Wang X; Zhuang W; Zheng Y; Liu B; Zhang L; Gao C
    J Immunol; 2021 Sep; 207(6):1652-1661. PubMed ID: 34426543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.
    Reay DP; Yang M; Watchko JF; Daood M; O'Day TL; Rehman KK; Guttridge DC; Robbins PD; Clemens PR
    Neurobiol Dis; 2011 Sep; 43(3):598-608. PubMed ID: 21624467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting proinflammatory NF-kappaB signaling using cell-penetrating NEMO binding domain peptides.
    Madge LA; May MJ
    Methods Mol Biol; 2009; 512():209-32. PubMed ID: 19347279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
    Solt LA; Madge LA; May MJ
    J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
    Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Mason NJ
    Clin Cancer Res; 2011 Jul; 17(14):4661-71. PubMed ID: 21610150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NBD peptides protect against ischemia reperfusion after orthotopic liver transplantation in rats.
    Cheng MX; Gong JP; Chen Y; Liu ZJ; Tu B; Liu CA
    J Surg Res; 2012 Aug; 176(2):666-71. PubMed ID: 22381173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis.
    Shibata W; Maeda S; Hikiba Y; Yanai A; Ohmae T; Sakamoto K; Nakagawa H; Ogura K; Omata M
    J Immunol; 2007 Sep; 179(5):2681-5. PubMed ID: 17709478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli.
    Berchtold CM; Wu ZH; Huang TT; Miyamoto S
    Mol Cell Biol; 2007 Jan; 27(2):497-509. PubMed ID: 17074802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
    Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
    Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.